loader from loading.io

Krista Brown: ATM Mutation, Delayed Diagnosis, and What Self-Advocacy Actually Costs

Walking the Genetic Line

Release Date: 04/24/2026

Krista Brown: ATM Mutation, Delayed Diagnosis, and What Self-Advocacy Actually Costs show art Krista Brown: ATM Mutation, Delayed Diagnosis, and What Self-Advocacy Actually Costs

Walking the Genetic Line

Guest: Krista (Oncology Nurse Navigator) Theme: Self-Advocacy, ATM Mutation, Cancer After Previvorhood   EPISODE SUMMARY When Krista's mother was 48, she became the first known cancer diagnosis in their family. She tested negative for BRCA mutations and felt relief — relief that she wouldn't pass anything on to her children. Twelve years later, just before entering hospice, she was offered expanded genetic testing and found out she carried a pathogenic ATM variant. She shared those results with her children. A few months after her death, Krista — 38 years old, a nurse, carrying...

info_outline
Ali Hall: Prophylactic Mastectomy, Queer Identity, and Claiming Your Body on Your Own Terms show art Ali Hall: Prophylactic Mastectomy, Queer Identity, and Claiming Your Body on Your Own Terms

Walking the Genetic Line

Guest: Ali Hall Theme: Queer Identity, Bodily Autonomy, and the BRCA Diagnosis Nobody Saw Coming Episode Summary When Ali Hall stole a 23andMe kit from a family white elephant exchange, she wasn't looking for anything life-changing. Five years later, an email arrived while she was picking her kid up from school: her results had been updated. She had a BRCA mutation. What followed wasn't panic — and that itself is the story. Ali's response was shaped by something older than the diagnosis: a lifelong pattern of minimizing her own experience when people around her were...

info_outline
Jennifer Mercer: Lynch Syndrome Awareness and the Weight of a Father's Legacy show art Jennifer Mercer: Lynch Syndrome Awareness and the Weight of a Father's Legacy

Walking the Genetic Line

Episode Summary Jennifer never knew her biological father growing up — and when she finally let him back into her life at 25, what he brought with him was a medical history that would change everything. Phone call after phone call, a new cancer. Eight-plus organ cancers. Over a hundred skin cancers. Years before anyone thought to offer him a genetic test. When Lynch Syndrome MSH2 was finally identified, Jennifer wasn't ready — she was a single mother, financially stretched, emotionally guarded, and carrying decades of unresolved grief toward a man who had never shown up for her. She put...

info_outline
Solo Episode: Living with Hereditary Cancer and Risk in a Loud World show art Solo Episode: Living with Hereditary Cancer and Risk in a Loud World

Walking the Genetic Line

Host: Sara Champie, LCSW Theme: Navigating medical vulnerability, global instability, and nervous system overwhelm during hereditary cancer risk and treatment. Episode summary What happens when your body is healing, your life is medically uncertain, and the world around you feels like it’s unraveling? In this solo episode, therapist Sara Champie explores a reality many people navigating hereditary cancer risk quietly experience: the nervous system strain of managing personal medical vulnerability while absorbing the constant noise of global crisis. When surgery, treatment, or high-stakes...

info_outline
Katie McMurray: The Emotional Impact of Grief, Sisterhood, and Preventative Surgery show art Katie McMurray: The Emotional Impact of Grief, Sisterhood, and Preventative Surgery

Walking the Genetic Line

Guest: Katie McMurray Theme: BRCA1, sisterhood, developmental trauma, and choosing preventative surgery in young adulthood Episode summary When Katie was 17, she lost her mother to breast cancer. Years later, genetic testing confirmed what she had long suspected: she carries a BRCA1 mutation. In this episode, Katie and Sara Champie explore what happens when grief resurfaces through genetic testing — how identity shifts, how fear and agency intertwine, and how the loss of a parent shapes medical decision-making. At 25, during the height of COVID, Katie chose preventative mastectomy surgery....

info_outline
Ingrid Nishimoto, LCSW: Peutz-Jeghers Syndrome and Intergenerational Emotional Inheritance show art Ingrid Nishimoto, LCSW: Peutz-Jeghers Syndrome and Intergenerational Emotional Inheritance

Walking the Genetic Line

Guest: Ingrid Nishimoto, LCSW Theme: Inherited Narratives—Moving Beyond the Parent’s Story to Claim Your Own Episode Summary When Ingrid Nishimoto was diagnosed with Peutz-Jeghers Syndrome at age 17, she wasn't just handed a medical management plan; she was handed a mirror of her father’s life and early death. In this profound conversation with Sara Champie, LCSW, Ingrid explores the "Time Collapse" that occurs when a genetic diagnosis makes the past and future converge in the present. As a fellow psychotherapist, Ingrid deconstructs the emotional burden of living past the age a parent...

info_outline
Sara Kavanaugh: From Health Anxiety to Empowerment—Transforming Hereditary Cancer Risk into Healing show art Sara Kavanaugh: From Health Anxiety to Empowerment—Transforming Hereditary Cancer Risk into Healing

Walking the Genetic Line

Guest: Sara Kavanaugh Theme: Living as a Previvor—Agency, Advocacy, and Reframing Anxiety After Genetic Testing Episode summary When Sara Kavanaugh learned she carried mutations in her MSH6 (Lynch syndrome) and Check2 genes, she moved from decades of health anxiety—and ambiguous uncertainty—to a new sense of empowerment and structure. In this dialogue with psychotherapist and fellow traveler Sara Champie, Sara shares how learning her genetic status fundamentally changed her identity, led her to fierce self-advocacy, and inspired her to create the Positive Gene Podcast—a resource and...

info_outline
Sara Kourouma: From Childhood Loss to Empowerment, Creating Community for BRCA Carriers show art Sara Kourouma: From Childhood Loss to Empowerment, Creating Community for BRCA Carriers

Walking the Genetic Line

Guest: Sara Kourouma Theme: Loss, agency, and community—the emotional journey of living with BRCA2 Episode summary When Sara Kourouma discovered she carried the BRCA2 mutation as a young adult—after losing her mother to breast cancer at age 10—she was thrust into a landscape defined by uncertainty, risk, and the weight of generational loss. In this episode, Sara Champie sits down with Sara Kourouma, a clinical social worker serving New York and Texas, to explore how privilege, access, grief, and human connection have shaped her journey through surveillance, multiple prophylactic...

info_outline
Beth Martinetti: Family, Fertility, and Identity after Hereditary Cancer Diagnosis show art Beth Martinetti: Family, Fertility, and Identity after Hereditary Cancer Diagnosis

Walking the Genetic Line

Episode Summary When Beth Martinetti—Pilates instructor, mother of three, and lifelong student of her own body—discovered multiple genetic mutations at 45, it was the latest chapter in a lifetime shaped by both visible and invisible challenges. Beth shares her journey from adolescent injury and Ehlers-Danlos diagnosis, through complicated pregnancies, to a midlife cascade: mysterious symptoms, pivotal encounters with validating doctors, and ultimately, the discovery that she carries BRCA1, CHEK2, and a variant in BARD1. Still in the thick of surgical recovery, Beth invites us into her...

info_outline
Dr. Corinne Menn: The Truth About Hormone Replacement for BRCA Carriers and Previvers show art Dr. Corinne Menn: The Truth About Hormone Replacement for BRCA Carriers and Previvers

Walking the Genetic Line

Guest: Dr. Corinne Menn Theme: Claiming agency in hereditary cancer risk, surgical menopause, and a new era of HRT care Episode summary When Dr. Corinne Menn—board certified OB/GYN, Menopause Society certified practitioner, 23+ year breast cancer survivor, and BRCA2 carrier—joins us, she brings unparalleled lived and clinical expertise to walking the genetic line. In this conversation, Dr. Corinne Menn shares her deeply personal journey: breast cancer at 28, the loss of her mother to ovarian cancer, and the years navigating her own genetic risk and premature menopause. Together, we...

info_outline
 
More Episodes

Guest: Krista (Oncology Nurse Navigator)

Theme: Self-Advocacy, ATM Mutation, Cancer After Previvorhood

 


EPISODE SUMMARY

When Krista's mother was 48, she became the first known cancer diagnosis in their family. She tested negative for BRCA mutations and felt relief — relief that she wouldn't pass anything on to her children. Twelve years later, just before entering hospice, she was offered expanded genetic testing and found out she carried a pathogenic ATM variant. She shared those results with her children. A few months after her death, Krista — 38 years old, a nurse, carrying twelve years of hospital vigils and treatment complications in her body — went in and requested her own testing.

What unfolds from that appointment is a story about what it actually takes to move through a healthcare system that doesn't know your mutation, that tells you the abnormality on your MRI is a lymph node, that sends you home with "come back in six months." Krista pushed for a biopsy that three specialists told her she didn't need. She was right. Her cancer diagnosis arrived two weeks before her scheduled preventive surgery. She now works as an oncology nurse navigator, walks patients through the same system she had to fight, and has built an educational platform for the hereditary cancer community — shaped entirely by what she wasn't told when she needed it most.


WE COVER

  • Testing too late, too little: Why Krista — a nurse with two generations of breast cancer in her family — was never offered genetic testing for twelve years, and what that delay meant for her outcomes.
  • The self-advocacy paradox: The tension of knowing something is wrong, having a medical background, identifying as a people-pleaser, and still having to push three specialists who said she was overreacting.
  • ATM mutation specifics: What carriers of ATM pathogenic variants actually face — including a 69% breast cancer risk, pancreatic and ovarian risk, and why the focus on BRCA leaves ATM carriers navigating without a map.
  • The middle phase nobody prepares you for: The psychological and bodily experience of bilateral mastectomy with flap reconstruction between the first and second surgery — including what it does to a woman's relationship with her own reflection.
  • Explaining hereditary cancer to children: How Krista told her daughters (ages 5, 8, and 10 at diagnosis) about her mutation, her surgery, and later her cancer — including what she had to process in herself first before she could speak from a calm place.
  • The grief that doesn't announce itself: How choosing surgery — a choice she felt grateful for — still produced grief she felt she wasn't allowed to have, and why "I chose this" doesn't close off mourning.
  • Cancer as identity reorganizer: How the experience shifted what Krista allows into her life, where she places her attention, and what felt insufficient about who she'd been before this began.
  • What the oncology system still misses: How even inside treatment, secondary risks (pancreatic, ovarian) get dropped after the primary intervention, and why mutation carriers need to track their full risk profile across specialties.

HIGHLIGHTS & TAKEAWAYS

  • Three specialists told her the abnormality wasn't cancer. She pushed anyway. That instinct — the unsettled feeling she couldn't explain — was the most accurate clinical information she had. Learning to trust it required overriding the authority gradient we're all trained to defer to.
  • The grief of choosing surgery is still grief. Knowing you're lucky, knowing you have options, knowing what you avoided — none of that neutralizes what it costs to look in the mirror at a body mid-reconstruction and not recognize yourself. Gratitude and loss occupy the same moment.
  • What she modeled for her daughters wasn't resilience. It was legibility — making the emotional experience visible and speakable so it could move through them instead of getting stored somewhere unnamed.
  • The shift from previvor to cancer diagnosis didn't happen at diagnosis. It had been accumulating across twelve years of watching her mother, then across the months of self-advocacy, then across a two-week window between a positive biopsy and surgery already on the calendar. The "before and after" is rarely a single moment.
  • She found her way into the hereditary cancer community not as someone who sought support, but as someone who had always been "fine." The connection she found there changed more than her career — it changed what she understood about what she'd actually needed all along.

CONTENT NOTE

This episode includes detailed discussion of a parent's cancer diagnosis and death, including end-of-life care and hospice. Krista also shares her own cancer diagnosis and surgical experience, including the psychological impact of bilateral mastectomy with reconstruction. The conversation includes reference to the loss of a sister-in-law to cancer at age 38.


RESOURCES MENTIONED

Guest resources:

  • Krista on Instagram: @cancer.prevention.coach — hereditary cancer education and advocacy content for the ATM and broader high-risk community

Standard links:

  • Face the Risk Together support groups: sarachampielcsw.com
  • FORCE (Facing Our Risk of Cancer Empowered): facingourrisk.org — national organization for hereditary cancer advocacy and peer support
  • National Society of Genetic Counselors (NSGC): nsgc.org — find a certified genetic counselor for hereditary cancer risk

CONNECT

If this conversation resonates, follow, rate, and share the show. Find Sara Champie on IG @sarachampielcsw and sarachampielcsw.com for free resources and access to 1:1 and group support. You already speak this language — come walk the genetic line with us. Sara Champie